2,246
Views
57
CrossRef citations to date
0
Altmetric
Research Article

A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk

, , , , , , , , , , , , , , , , & show all
Pages 767-775 | Received 13 Nov 2009, Accepted 21 Mar 2010, Published online: 07 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carl Wibom, Sara Sjöström, Roger Henriksson, Thomas Brännström, Helle Broholm, Patrik Rydén, Christoffer Johansen, Helle Collatz-Laier, Sara Hepworth, Patricia A. McKinney, Lara Bethke, Richard S. Houlston, Ulrika Andersson & Beatrice S. Melin. (2012) DNA-repair gene variants are associated with glioblastoma survival. Acta Oncologica 51:3, pages 325-332.
Read now

Articles from other publishers (56)

Marina Petkovic, Müge Yalçin, Oliver Heese & Angela Relógio. (2023) Differential expression of the circadian clock network correlates with tumour progression in gliomas. BMC Medical Genomics 16:1.
Crossref
Jianglong Lu, Fanjie Xu, Changjun Rao, Chaodong Shen, Jinghao Jin, Zhangzhang Zhu, Chengde Wang & Qun Li. (2022) Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology. Frontiers in Pharmacology 13.
Crossref
Wendy Yi-Ying Wu, Anna M Dahlin, Carl Wibom, Benny Björkblom & Beatrice Melin. (2022) Prediagnostic biomarkers for early detection of glioma—using case–control studies from cohorts as study approach. Neuro-Oncology Advances 4:Supplement_2, pages ii73-ii80.
Crossref
Frank Saran, Liam Welsh, Allan James, Catherine McBain, Rao Gattamaneni, Sarah Jefferies, Fiona Harris, Karine Pemberton, Jennifer Schaible, Shaun Bender, Agnieszka Cseh & Michael Brada. (2021) Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial. Journal of Neuro-Oncology 155:3, pages 307-317.
Crossref
Chun-Ting Lin, Ting-Hao Chen, Chen-Cheng Yang, Kuei-Hau Luo, Tzu-Hua Chen & Hung-Yi Chuang. (2021) Epidermal Growth Factor Receptor (EGFR) Gene Polymorphism May be a Modifier for Cadmium Kidney Toxicity. Genes 12:10, pages 1573.
Crossref
Alexandr N. Chernov, Diana A. Alaverdian, Elvira S. Galimova, Alessandra Renieri, Elisa Frullanti, Ilaria Meloni & Olga V. Shamova. (2021) The phenomenon of multidrug resistance in glioblastomas. Hematology/Oncology and Stem Cell Therapy.
Crossref
Ernest Osei, Pascale Walters, Olivia Masella, Quinton Tennant, Amber Fishwick, Eugenia Dadzie, Anmol Bhangu & Johnson Darko. (2019) A review of predictive, prognostic and diagnostic biomarkers for brain tumours: towards personalised and targeted cancer therapy. Journal of Radiotherapy in Practice 20:1, pages 83-98.
Crossref
Antonietta Arcella, Fiona Limanaqi, Rosangela Ferese, Francesca Biagioni, Maria Antonietta Oliva, Marianna Storto, Mirco Fanelli, Stefano Gambardella & Francesco Fornai. (2020) Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers. International Journal of Molecular Sciences 21:2, pages 685.
Crossref
Wendy Yi-Ying Wu, Gunnar Johansson, Carl Wibom, Thomas Brännström, Annika Malmström, Roger Henriksson, Irina Golovleva, Melissa L. Bondy, Ulrika Andersson, Anna M. Dahlin & Beatrice Melin. (2019) The Genetic Architecture of Gliomagenesis–Genetic Risk Variants Linked to Specific Molecular Subtypes. Cancers 11:12, pages 2001.
Crossref
Ulrika Andersson, Sofie Degerman, Anna M. Dahlin, Carl Wibom, Gunnar Johansson, Melissa L. Bondy & Beatrice S. Melin. (2018) The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking. Cancer Causes & Control 30:2, pages 177-185.
Crossref
Guiyan Xu & Jian Yi Li. (2017) CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component. Journal of Neuro-Oncology 136:3, pages 445-452.
Crossref
Wolfgang Wick, Matthias Osswald, Antje Wick & Frank Winkler. (2018) Treatment of glioblastoma in adults. Therapeutic Advances in Neurological Disorders 11, pages 175628641879045.
Crossref
Rui Liu, Yiping Qu, Lihong Chen, Jun Pu, Sharui Ma, Xiaozhi Zhang, Qi Yang, Bingyin Shi, Peng Hou & Meiju Ji. (2017) Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients. Oncotarget 8:54, pages 92275-92288.
Crossref
Xiao Yu, Nian Rong Sun, Hai Tao Jang, Shi Wen Guo & Min Xue Lian. (2017) Associations between EGFR gene polymorphisms and susceptibility to glioma: a systematic review and meta-analysis from GWAS and case-control studies. Oncotarget 8:49, pages 86877-86885.
Crossref
Peng Zhao, Anjing Chen, Qichao Qi, Wenjing Zhou, Zichao Feng, Jiwei Wang, Ning Yang, Xingang Li, Jian Wang, Qibing Huang & Bin Huang. (2017) Impact of VEGFA polymorphisms on glioma risk in Chinese . Oncotarget 8:48, pages 83712-83722.
Crossref
Mengdan Yan, Jingjie Li, Na He, Xugang Shi, Shuli Du, Bin Li & Tianbo Jin. (2017) A case-control study of the association between the EGFR gene and glioma risk in a Chinese Han population . Oncotarget 8:35, pages 59823-59830.
Crossref
Pauline Quach, Reem El Sherif, James Gomes & Daniel Krewksi. (2017) A systematic review of the risk factors associated with the onset and progression of primary brain tumours. NeuroToxicology 61, pages 214-232.
Crossref
Edward A. Rietman, Jacob G. Scott, Jack A. Tuszynski & Giannoula Lakka Klement. (2016) Personalized anticancer therapy selection using molecular landscape topology and thermodynamics. Oncotarget 8:12, pages 18735-18745.
Crossref
Amélie Darlix, Catherine Gozé, Valérie Rigau, Luc Bauchet, Luc Taillandier & Hugues Duffau. 2017. Diffuse Low-Grade Gliomas in Adults. Diffuse Low-Grade Gliomas in Adults 703 727 .
Glaucia C. Pereira. 2017. Biotechnology and Production of Anti-Cancer Compounds. Biotechnology and Production of Anti-Cancer Compounds 253 281 .
Maral Adel Fahmideh, Catharina Lavebratt, Joachim Schüz, Martin Röösli, Tore Tynes, Michael A. Grotzer, Christoffer Johansen, Claudia E Kuehni, Birgitta Lannering, Michaela Prochazka, Lisbeth S Schmidt & Maria Feychting. (2016) Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility. Oncotarget 7:39, pages 63640-63650.
Crossref
Bin Li, Wenhui Zhao, Jingjie Li, Mengdan Yan, Zhilan Xie, Yuanyuan Zhu, Chao Chen & Tianbo Jin. (2016) Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients. Oncotarget 7:39, pages 63054-63064.
Crossref
Florentin Späth, Ulrika Andersson, Anna M. Dahlin, Hilde Langseth, Eivind Hovig, Tom Børge Johannesen, Kjell Grankvist, Benny Björkblom, Carl Wibom & Beatrice Melin. (2016) Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study. Tumor Biology 37:8, pages 11065-11072.
Crossref
Jiannan Zhang, Jian Yang, Yuqing Chen, Qin Mao, Shanquan Li, Wenhao Xiong, Yingying Lin, Jie Chen & Jianwei Ge. (2015) Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study. Molecular Neurobiology 53:4, pages 2610-2618.
Crossref
Yufei Gao, Piyong Ma, Yichun He, Yan Liu & Yang Jiang. (2015) Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas. Molecular Neurobiology 53:4, pages 2541-2549.
Crossref
Soma Ghasimi, Carl Wibom, Anna M. Dahlin, Thomas Brännström, Irina Golovleva, Ulrika Andersson & Beatrice Melin. (2016) Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Journal of Neuro-Oncology 127:3, pages 483-492.
Crossref
Jad Alshami, Marie-Christine Guiot, Scott Owen, Petr Kavan, Neil Gibson, Flavio Solca, Agnieszka Cseh, David A. Reardon & Thierry Muanza. (2015) Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report. Oncotarget 6:32, pages 34030-34037.
Crossref
Shui-Ying Tsang, Lingling Mei, Weiqing Wan, Jun Li, Yi Li, Cunyou Zhao, Xiaofan Ding, Frank W. Pun, Xiaoxia Hu, Jianmin Wang, Junyi Zhang, Rongcheng Luo, Siu-Tim Cheung, Gilberto K. K. Leung, Wai-Sang Poon, Ho-Keung Ng, Liwei Zhang & Hong Xue. (2015) Glioma Association and Balancing Selection of ZFPM2. PLOS ONE 10:7, pages e0133003.
Crossref
Michael Weller, Wolfgang Wick, Ken Aldape, Michael Brada, Mitchell Berger, Stefan M. Pfister, Ryo Nishikawa, Mark Rosenthal, Patrick Y. Wen, Roger Stupp & Guido Reifenberger. (2015) Glioma. Nature Reviews Disease Primers 1:1.
Crossref
Ketao Mu, Shun Zhang, Tao Ai, Jingjing Jiang, Yihao Yao, Lingyu Jiang, Qing Zhou, Hongbing Xiang, Yanhong Zhu, Xiangliang Yang & Wenzhen Zhu. (2015) Monoclonal Antibody–Conjugated Superparamagnetic Iron Oxide Nanoparticles for Imaging of Epidermal Growth Factor Receptor–Targeted Cells and Gliomas. Molecular Imaging 14:5, pages 7290.2015.00002.
Crossref
Carl Wibom, Florentin Späth, Anna M. Dahlin, Hilde Langseth, Eivind Hovig, Preetha Rajaraman, Tom Børge Johannesen, Ulrika Andersson & Beatrice Melin. (2015) Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case–Control Study. Cancer Epidemiology, Biomarkers & Prevention 24:5, pages 810-816.
Crossref
Christina Backes, Christian Harz, Ulrike Fischer, Jana Schmitt, Nicole Ludwig, Britt-Sabina Petersen, Sabine C. Mueller, Yoo-Jin Kim, Nadine M. Wolf, Hugo A. Katus, Benjamin Meder, Rhoikos Furtwängler, Andre Franke, Rainer Bohle, Wolfram Henn, Norbert Graf, Andreas Keller & Eckart Meese. (2014) New insights into the genetics of glioblastoma multiforme by familial exome sequencing. Oncotarget 6:8, pages 5918-5931.
Crossref
Christopher Fung, Pei Zhou, Sonali Joyce, Kerry Trent, Jian-Min Yuan, Jennifer R. Grandis, Joel L. Weissfeld, Marjorie Romkes, Daniel E. Weeks & Ann Marie Egloff. (2015) Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma. Cancer Letters 357:2, pages 549-556.
Crossref
Xinyu WangHuawei ZhangDonghai WangXingang Li. (2015) Association of Genetic Polymorphisms of EGFR with Glioma in a Chinese Population . Genetic Testing and Molecular Biomarkers 19:1, pages 59-62.
Crossref
Sara G.M. Piccirillo, Sue Colman, Nicola E. Potter, Frederik W. van Delft, Suzanne Lillis, Maria-Jose Carnicer, Lyndal Kearney, Colin Watts & Mel Greaves. (2015) Genetic and Functional Diversity of Propagating Cells in Glioblastoma. Stem Cell Reports 4:1, pages 7-15.
Crossref
Zhichao Li, Yaming Wang, Xinru Guo, Leiming Zhang, Chao Dong & Jianning Zhang. (2014) Assessment of Glioma Risk Associated with an Inherited Variant at Chromosome 11q23. Cell Biochemistry and Biophysics 71:1, pages 69-75.
Crossref
D. A. Reardon, L. B. Nabors, W. P. Mason, J. R. Perry, W. Shapiro, P. Kavan, D. Mathieu, S. Phuphanich, A. Cseh, Y. Fu, J. Cong, S. Wind & D. D. Eisenstat. (2014) Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma. Neuro-Oncology.
Crossref
Yu-Shu Dong, Wu-Gang Hou, Xiao-Lan Li, Tian-Bo Jin, Yue Li, Da-Yun Feng, De-Bao Liu, Guo-Dong Gao, Zhong-Min Yin & Huai-Zhou Qin. (2014) Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population. Tumor Biology 35:5, pages 4937-4941.
Crossref
Beatrice Melin & Robert Jenkins. (2013) Genetics in glioma. Current Opinion in Neurology 26:6, pages 688-692.
Crossref
Tian-Bo Jin, Jia-Yi Zhang, Gang Li, Shu-Li Du, Ting-Ting Geng, Jing Gao, Qian-Ping Liu, Guo-Dong Gao, Long-Li Kang, Chao Chen & Shan-Qu Li. (2013) RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population. Tumor Biology 34:6, pages 3659-3666.
Crossref
Jan B VermorkenPol Specenier. 2013. Monoclonal Antibodies Targeting EGFR/HER2 and Clinical Outcomes in Cancer Treatment. Monoclonal Antibodies Targeting EGFR/HER2 and Clinical Outcomes in Cancer Treatment 72 89 .
Mingjun Hu, Hangyu Shi, Zanfeng Xu & Weiping Liu. (2013) Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma. Tumor Biology 34:3, pages 1879-1885.
Crossref
T. Rice, S. Zheng, P. A. Decker, K. M. Walsh, P. Bracci, Y. Xiao, L. S. McCoy, I. Smirnov, J. S. Patoka, H. M. Hansen, G. Hsuang, J. L. Wiemels, T. Tihan, A. R. Pico, M. D. Prados, S. M. Chang, M. S. Berger, A. Caron, S. Fink, T. Kollmeyer, A. Rynearson, J. Voss, M. L. Kosel, B. L. Fridley, D. H. Lachance, J. E. Eckel-Passow, H. Sicotte, B. P. O'Neill, C. Giannini, J. K. Wiencke, R. B. Jenkins & M. R. Wrensch. (2013) Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro-Oncology 15:5, pages 535-541.
Crossref
Murielle Mimeault & Surinder K. Batra. (2013) Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells. Journal of Cellular and Molecular Medicine 17:1, pages 30-54.
Crossref
Carl Wibom, Soma Ghasimi, Peter Van Loo, Thomas Brännström, Johan Trygg, Ching Lau, Roger Henriksson, Tommy Bergenheim, Ulrika Andersson, Patrik Rydén & Beatrice Melin. (2012) EGFR Gene Variants Are Associated with Specific Somatic Aberrations in Glioma. PLoS ONE 7:12, pages e47929.
Crossref
Gang Li, Tian-Bo Jin, Xiao-Bin Wei, Shi-Ming He, Hong-Juan Liang, Hai-Xia Yang, Yan Cui, Chao Chen, Lin-Bo Cai & Guo-Dong Gao. (2012) Selected polymorphisms of GSTP1 and TERT were associated with glioma risk in Han Chinese. Cancer Epidemiology 36:6, pages 525-527.
Crossref
McKinsey L. Goodenberger & Robert B. Jenkins. (2012) Genetics of adult glioma. Cancer Genetics 205:12, pages 613-621.
Crossref
Hai-Bo Liu, Yu-Ping Peng, Chang-Wu Dou, Xiu-Lan Su, Nai-Kang Gao, Fu-Ming Tian & Jie Bai. (2012) Comprehensive Study on Associations Between Nine SNPs and Glioma Risk. Asian Pacific Journal of Cancer Prevention 13:10, pages 4905-4908.
Crossref
Hao Ye, LinLin Yang, ZhiWei Cao, KaiLin Tang & YiXue Li. (2012) A pathway profile-based method for drug repositioning. Chinese Science Bulletin 57:17, pages 2106-2112.
Crossref
Wu-Gang Hou, Wen-Bo Ai, Xiao-Guang Bai, Hai-Long Dong, Zhen Li, Yuan-Qiang Zhang & Li-Ze Xiong. (2012) Genetic Variation in the EGFR Gene and the Risk of Glioma in a Chinese Han Population. PLoS ONE 7:5, pages e37531.
Crossref
Bruno Marques Costa, Marta Viana-Pereira, Ricardo Fernandes, Sandra Costa, Paulo Linhares, Rui Vaz, Céline Pinheiro, Jorge Lima, Paula Soares, Ana Silva, Fernando Pardal, Júlia Amorim, Rui Nabiço, Rui Almeida, Carlos Alegria, Manuel Melo Pires, Célia Pinheiro, Ernesto Carvalho, Pedro Oliveira, José M. Lopes & Rui M. Reis. (2011) Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome . Cancer Epidemiology, Biomarkers & Prevention 20:12, pages 2610-2617.
Crossref
Seongman Kang & Sunghoi Hong. (2011) Prediction of personalized drugs based on genetic variations provided by DNA sequencing technologies. Genes & Genomics 33:6, pages 591-603.
Crossref
Beatrice Melin. (2011) Genetic causes of glioma. Current Opinion in Oncology 23:6, pages 643-647.
Crossref
Murielle Mimeault & Surinder K. Batra. (2011) Complex Oncogenic Signaling Networks Regulate Brain Tumor-Initiating Cells and Their Progenies: Pivotal Roles of Wild-Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies. Brain Pathology, pages no-no.
Crossref
Joanna Reszec, Piotr S. Bernaczyk, Robert Milewski, Lech Chyczewski & Zenon Mariak. (2011) c-erbB-2 protein expression in astrocytic tumors of the brain. Medical Science Monitor 17:8, pages BR216-BR220.
Crossref
Judith A. Schwartzbaum, Yuanyuan Xiao, Yanhong Liu, Spyros Tsavachidis, Mitchel S. Berger, Melissa L. Bondy, Jeffrey S. Chang, Susan M. Chang, Paul A. Decker, Bo Ding, Sarah J. Hepworth, Richard S. Houlston, Fay J. Hosking, Robert B. Jenkins, Matthew L. Kosel, Lucie S. McCoy, Patricia A. McKinney, Kenneth Muir, Joe S. Patoka, Michael Prados, Terri Rice, Lindsay B. Robertson, Minouk J. Schoemaker, Sanjay Shete, Anthony J. Swerdlow, Joe L. Wiemels, John K. Wiencke, Ping Yang & Margaret R. Wrensch. (2010) Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis 31:10, pages 1770-1777.
Crossref